Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,773 | 534 | 98.6% |
| Education | $112.65 | 2 | 1.1% |
| Gift | $27.28 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,306 | 134 | $0 (2024) |
| Janssen Biotech, Inc. | $1,452 | 93 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $954.65 | 52 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $660.73 | 49 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $600.23 | 34 | $0 (2024) |
| Celgene Corporation | $397.23 | 24 | $0 (2024) |
| GENZYME CORPORATION | $366.20 | 17 | $0 (2024) |
| Olympus America Inc. | $346.12 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $288.42 | 5 | $0 (2024) |
| PFIZER INC. | $256.90 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,090 | 110 | Janssen Biotech, Inc. ($605.29) |
| 2023 | $1,950 | 109 | ABBVIE INC. ($561.97) |
| 2022 | $1,811 | 89 | ABBVIE INC. ($572.89) |
| 2021 | $1,025 | 55 | Janssen Biotech, Inc. ($209.30) |
| 2020 | $409.84 | 29 | IRONWOOD PHARMACEUTICALS, INC ($159.93) |
| 2019 | $874.61 | 46 | AbbVie, Inc. ($257.66) |
| 2018 | $638.61 | 37 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($152.22) |
| 2017 | $1,113 | 63 | AbbVie, Inc. ($231.01) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| Category: GI | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.84 | General |
| 11/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: GI | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Immunology | ||||||
| 10/31/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: GI | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Gastroenterology | ||||||
| 10/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 10/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: LIVER DISEASE | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,874 | 19,555 | $843,759 | $327,320 |
| 2022 | 25 | 1,750 | 12,280 | $814,383 | $265,316 |
| 2021 | 31 | 2,300 | 20,519 | $1.0M | $362,490 |
| 2020 | 29 | 2,523 | 26,939 | $1.1M | $425,196 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 11 | 5,100 | $127,500 | $87,714 | 68.8% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 12 | 1,820 | $91,000 | $48,526 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 374 | 469 | $65,660 | $38,635 | 58.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 144 | 144 | $117,360 | $27,217 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 217 | 217 | $40,616 | $22,239 | 54.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 107 | 528 | $29,040 | $18,744 | 64.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 107 | 308 | $23,100 | $14,469 | 62.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 196 | 208 | $93,600 | $12,710 | 13.6% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 61 | 62 | $16,464 | $9,727 | 59.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 47 | 47 | $27,260 | $8,044 | 29.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 70 | 72 | $85,100 | $6,683 | 7.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 62 | 63 | $43,155 | $5,419 | 12.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $20,300 | $4,564 | 22.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 24 | 42 | $8,820 | $3,836 | 43.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $9,280 | $2,772 | 29.9% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 21 | 23 | $5,220 | $2,758 | 52.8% |
| 43450 | Dilation of esophagus | Facility | 2023 | 61 | 62 | $13,330 | $1,866 | 14.0% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 47 | 49 | $3,288 | $1,854 | 56.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $2,941 | $1,585 | 53.9% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 19 | 19 | $2,470 | $1,450 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $2,400 | $1,338 | 55.7% |
| 74160 | Ct scan of abdomen with contrast | Office | 2023 | 12 | 12 | $2,454 | $1,324 | 54.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 97 | 10,100 | $5,050 | $1,176 | 23.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $5,005 | $920.35 | 18.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 20 | $1,100 | $704.20 | 64.0% |
About Dr. William Mclaughlin, MD
Dr. William Mclaughlin, MD is a Gastroenterology healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104870971.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Mclaughlin, MD has received a total of $9,913 in payments from pharmaceutical and medical device companies, with $2,090 received in 2024. These payments were reported across 538 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,773).
As a Medicare-enrolled provider, Mclaughlin has provided services to 8,447 Medicare beneficiaries, totaling 79,293 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Dothan, AL
- Active Since 05/19/2006
- Last Updated 01/13/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104870971
Products in Payments
- STELARA (Biological) $1,359
- RINVOQ (Biological) $604.40
- DUPIXENT (Biological) $511.98
- TRULANCE (Drug) $490.54
- ENTYVIO (Biological) $447.67
- LINZESS (Drug) $444.92
- Linzess (Drug) $395.85
- Humira (Biological) $394.43
- SKYRIZI (Biological) $379.45
- ZEPOSIA (Drug) $363.33
- XIFAXAN (Drug) $305.59
- EVIS EXERA lll COLONOVIDEOSCOPE (Device) $262.52
- Epclusa (Drug) $237.51
- TREMFYA (Drug) $227.22
- DIFICID (Drug) $216.94
- HUMIRA (Biological) $212.40
- XELJANZ (Drug) $210.65
- CREON (Drug) $171.92
- VIBERZI (Drug) $159.46
- IBSRELA (Drug) $154.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dothan
Mr. Travis Rutland, Md, MD
Gastroenterology — Payments: $265,022
Dr. Paul Lamb, Md, MD
Gastroenterology — Payments: $111,968
Scott Sarrels, M.d, M.D
Gastroenterology — Payments: $15,718
Samuel Tarwater, Md, MD
Gastroenterology — Payments: $15,397
George Nelson, M.d, M.D
Gastroenterology — Payments: $8,417
Jeffrey Crittenden, Md, MD
Gastroenterology — Payments: $8,300